Ocular Therapeutix (OCUL)
(Delayed Data from NSDQ)
$7.60 USD
+0.44 (6.15%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $7.59 -0.01 (-0.13%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Ocular Therapeutix, Inc. [OCUL]
Reports for Purchase
Showing records 81 - 88 ( 88 total )
Company: Ocular Therapeutix, Inc.
Industry: Medical - Drugs
Dextenza NDA Resubmission Imminent; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ocular Therapeutix, Inc.
Industry: Medical - Drugs
2018 1Q Results Reported; Dextenza NDA Resubmission This Quarter; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ocular Therapeutix, Inc.
Industry: Medical - Drugs
2017 Results Reported; Dextenza NDA Resubmission on Track in 1H18; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ocular Therapeutix, Inc.
Industry: Medical - Drugs
Our Impressions of the American Academy of Ophthalmology (AAO) 2017 Meeting
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ocular Therapeutix, Inc.
Industry: Medical - Drugs
3Q17 Results Reported; Dextenza NDA Resubmission in 1H 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ocular Therapeutix, Inc.
Industry: Medical - Drugs
2Q17 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Ocular Therapeutix, Inc.
Industry: Medical - Drugs
New CEO Commenced Employment; Restructuring Starts; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Ocular Therapeutix, Inc.
Industry: Medical - Drugs
A Sustained Delivery Platform for Your Eyes; Initiating Coverage at Buy and $10 Price Target
Provider: H.C. Wainwright & Co., Inc.